Drug
Pancrelipase clinical trials
Also written Creon, Zenpep, Pancreatin and SA-001.
- studies test it
- 43
- open now
- 3
- in phase 3
- 11
- first study started
- 1999
Keep track of what changes. Save the Pancrelipase studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
43 studies that test it; most in 2008 (5)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 9
- Phase 3
- 11
- Phase 4
- 15
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 18
Forest Laboratories (6) · Abbott (5) · AbbVie (4) · Abbott Products (3) · Digestive Care, Inc. (3) · Samjin Pharmaceutical Co., Ltd. (2) · Solvay Pharmaceuticals (2) · Memorial Sloan Kettering Cancer Center (1)
Often tested with
Tested in the same studies.
Bifidobacterium longum subsp. infantis (1) · Nitazoxanide (1) · Bicarbonates (1) · Esomeprazole (1)
Studies
Open first, then newest update. How each study uses Pancrelipase is read from its arms, and is right about nine times in ten.
Testing it · 43
- Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 DiabetesRecruitingPhase 4Silesian Centre for Heart DiseasesNCT07852988Written as Pancreatin
- Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)RecruitingNot applicablePhilipp SchuetzNCT06826105Written as Zenpep
- Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic InsufficiencyRecruitingPhase 4Ohio State UniversityNCT06477159Written as Pancrelipase Capsules
- Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Active, not recruitingPhase 1/2Memorial Sloan Kettering Cancer CenterNCT05642962Written as Pertzye
- Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic InsufficiencyActive, not recruitingPhase 2Andrew Hendifar, MDNCT04098237Written as Pancrelipase
- Effect of Enzyme Therapy on Protein Metabolism in Chronic PancreatitisCompletedNot applicableInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementNCT01154608Written as Creon
- Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 DiabetesCompletedEarly Phase 1Vanderbilt University Medical CenterNCT05266963Written as CREON
- Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With CreonCompletedPhase 4AbbVieNCT05069597Written as CREON
- A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedPhase 4AbbVieNCT03924947Written as Pancrelipase
- A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)TerminatedPhase 4AbbVieNCT03859869Written as Pancrelipase
- Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's SyndromeCompletedPhase 2Samjin Pharmaceutical Co., Ltd.NCT05269810Written as SA001 Low dose
- Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.CompletedPhase 2Samjin Pharmaceutical Co., Ltd.NCT03723798Written as SA001 Low dose
- Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic CancerWithdrawnPhase 4AbbVieNCT04315311Written as CREON
- PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic CancerTerminatedPhase 1/2Massimo Raimondo, M.D.NCT02985801Written as Pancrelipase
- Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic FibrosisCompletedNot applicableUniversity of Colorado, DenverNCT02372383Written as Pancrelipase
- Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaTerminatedPhase 2Dana-Farber Cancer InstituteNCT03469258Written as Pancrelipase
- Creon Use in Coeliac Patients With Low Faecal Pancreatic ElastaseTerminatedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT01865695Written as Creon
- Fat Malabsorption in Chronic PancreatitisCompletedPhase 2Children's Hospital of PhiladelphiaNCT02849704Written as Creon36™
- Irritable Bowel Syndrome Evaluation and Treatment in Primary CareCompletedPhase 4American Academy of Family PhysiciansNCT01641341Written as Pancrelipase
- Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic PancreatitisWithdrawnPhase 2Dartmouth-Hitchcock Medical CenterNCT02706236Written as Pancrelipase
See all 43 studies that test Pancrelipase →
Given in every arm · 1 — Pancrelipase is usual care beside what is tested
As the comparator · 4 — what is tested is compared with Pancrelipase
- Phase 2 Study to Assess the Safety and Efficacy of ANG003RecruitingPhase 2Anagram Therapeutics, Inc.NCT07450547Written as Creon
- CREON for the Treatment of Post-RYGB HypoglycemiaTerminatedPhase 1East Carolina UniversityNCT02733848Written as Creon
- A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal PainTerminatedPhase 1Forest LaboratoriesNCT01159119Written as Zenpep
- Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic InsufficiencyStatus unknownPhase 2/3Azidus BrasilNCT01012908Written as Creon
Codes
What other systems call Pancrelipase · ClinicalTrials.gg INT008771
- MeSH (NLM) D020799PancrelipaseConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) FQ3DRG0N5KPANCRELIPASEConfirmed FDA, Wikidata
- RxNorm 235379Confirmed FDA, Wikidata
- Wikidata Q7130425pancrelipaseConfirmed FDA, Wikidata
- NCI Thesaurus C29345PancrelipaseOne source FDA
- DrugBank DB00085One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020799 | Pancrelipase | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | FQ3DRG0N5K | PANCRELIPASE | Confirmed FDA, Wikidata |
| RxNorm | 235379 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7130425 | pancrelipase | Confirmed FDA, Wikidata |
| NCI Thesaurus | C29345 | Pancrelipase | One source FDA |
| DrugBank | DB00085 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.